D. Nöteberg

Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.

D. Nöteberg, Elizabeth Hamelink, J. Hulten, 2003, Journal of medicinal chemistry.

New proline mimetics: synthesis of thrombin inhibitors incorporating cyclopentane- and cyclopentenedicarboxylic acid templates in the P2 position. Binding conformation investigated by X-ray crystallography.

D. Nöteberg, B. Samuelsson, D. Musil, 2000, Journal of medicinal chemistry.

Synthesis of enantiomerically pure cis and trans 2-aminocyclopentanecarboxylic acids. Use of proline replacements in potential HIV-protease inhibitors

D. Nöteberg, B. Samuelsson, A. Hallberg, 1997 .

High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II.

D. Nöteberg, Elizabeth Hamelink, L. Vrang, 2003, Journal of combinatorial chemistry.

Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

David C. Wood, K. Fennell, R. Kurumbail, 2018, Journal of medicinal chemistry.

Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.

D. Nöteberg, Elizabeth Hamelink, L. Vrang, 2005, Bioorganic & medicinal chemistry.